Volitionrx (VNRX) Interest Coverage Ratio (2013 - 2025)
Volitionrx (VNRX) posted Interest Coverage Ratio of 57.98 for Q4 2025, up 826.6% on a QoQ basis from 7.98 in Q3 2025, and up 192.75% year-over-year from 19.8 in Q4 2024.
Volitionrx (VNRX) Interest Coverage Ratio (2013 - 2025) Analysis & Trends
Volitionrx's Interest Coverage Ratio history runs 9 years deep, the most recent figure standing at 57.98 for Q4 2025.
- Quarterly Interest Coverage Ratio rose 192.75% year-over-year to 57.98 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 138.61 (down 52.43% YoY) and the FY2025 annual result came in at 0.44, up 32.32% from the prior year.
- Interest Coverage Ratio was 57.98 for Q4 2025 at Volitionrx, up from 7.98 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 57.98 in Q4 2025 and bottomed at 249.81 in Q4 2021.
- A 5-year average of 50.43 and a median of 15.66 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio sank 2139.75% — and 2025, when it jumped 192.75%.
- Volitionrx's Interest Coverage Ratio stood at 249.81 in 2021, then surged by 43.99% to 139.92 in 2022, then decreased by 7.7% to 150.7 in 2023, then jumped by 58.52% to 62.51 in 2024, then soared by 192.75% to 57.98 in 2025.
- Business Quant data shows VNRX's Interest Coverage Ratio at 57.98 in Q4 2025, 7.98 in Q3 2025, and 14.47 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 82.35 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 5.36 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -2.90 |
| 10 | Volitionrx | 89,525.10 | -1.03 Mn | - | 57.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57.98 |
| Sep 30, 2025 | -7.98 |
| Jun 30, 2025 | -14.47 |
| Mar 31, 2025 | -13.32 |
| Dec 31, 2024 | -62.51 |
| Sep 30, 2024 | -65.60 |
| Jun 30, 2024 | -15.40 |
| Mar 31, 2024 | -17.75 |
| Dec 31, 2023 | -150.70 |
| Sep 30, 2023 | -15.91 |
| Jun 30, 2023 | -16.42 |
| Mar 31, 2023 | -13.98 |
| Dec 31, 2022 | -139.92 |
| Sep 30, 2022 | -17.76 |
| Jun 30, 2022 | -218.01 |
| Mar 31, 2022 | -14.39 |
| Dec 31, 2021 | -249.81 |
| Sep 30, 2021 | -13.03 |
| Jun 30, 2021 | -9.73 |
| Mar 31, 2021 | -9.93 |